Prolonged waterlogging, in turn, depletes oxygen in the soil, leading to root rot and other plant diseases ... Box”, lemon scented myrtle, lilly pilly, Nandina, Pennisetum “Nafray ...

Lilly's drug is one of several being tested to treat high Lp(a), a risk factor for heart disease that affects an estimated 1.4 billion people worldwide, including 64 million people in the United ...

Eli Lilly is expanding its menu of direct-to-consumer ... users to both in-person and virtual care options for Alzheimer’s disease. The new offering is focused on shortening the time it takes ...

Eli Lilly experienced a 6% increase in price over ... levels, a genetic heart disease risk factor. Additionally, the company's expansion in digital healthcare and strategic partnerships, like ...

Eli Lilly & Co. is adding Alzheimer’s disease resources to the online platform it launched a year ago to sell obesity, diabetes and migraine medicines. Patients will now be able to use ...

Eli Lilly And Co (NYSE:LLY), on Sunday ... [Lp(a)], a genetically inherited risk factor for heart disease. In the Phase 2 ALPACA study, lepodisiran significantly reduced Lp(a) levels by an ...

Eli Lilly (NYSE:LLY) released positive Phase 2 ... The trial results showed 94% lower levels of a genetically inherited heart disease risk factor in adults with elevated risk taking the highest ...

Beech leaf disease (BLD) has caused significant mortality and reduced growth in American beech trees, with 30% of trees dying since its detection in northeast Ohio in 2014.

Now, Eli Lilly is hoping to spark a similar change in how common diseases are represented on-screen, too. The Big Pharma recently sponsored a study by the USC Annenberg Inclusion Initiative that ...

CHICAGO (Reuters) - The highest dose of an experimental drug developed by Eli Lilly significantly reduced levels of a genetically inherited risk factor for heart disease in a midstage trial ...